ORGANOGENESIS HOLDINGS INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 104.71 million shares for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2020-08-10
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 104.71M shares, a 15.52% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 104.49M shares, a 15.32% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-12-31 was 97.81M shares, a 27.11% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-09-30 was 92.28M shares, a 32.78% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 92.84M shares, a 33.93% increase from fiscal 2018.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 69.32M shares, a 8.52% increase from fiscal 2017.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 63.88M shares, a 1.08% increase from fiscal 2016.
- ORGANOGENESIS HOLDINGS INC. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 63.20M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 1 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | 104.71M shares 10-Q · filed 2020-08-10 | 104.60M shares 10-Q · filed 2020-08-10 | 102.34M shares derived: average of 3 quarters · filed 2020-08-10 | 99.82M shares derived: average of 4 quarters · filed 2020-08-10 | |||||
| 2020-03-31 | 104.49M shares 10-Q · filed 2020-05-11 | 101.15M shares derived: average of 2 quarters · filed 2020-05-11 | 98.19M shares derived: average of 3 quarters · filed 2020-05-11 | 96.31M shares derived: average of 4 quarters · filed 2020-08-10 | |||||
| 2019-12-31 | 97.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | 95.05M shares derived: average of 2 quarters · filed 2020-03-09 | 93.58M shares derived: average of 3 quarters · filed 2020-08-10 | 92.84M shares 10-K · filed 2020-03-09 | |||||
| 2019-09-30 | 92.28M shares 10-Q · filed 2019-11-12 | 91.46M shares derived: average of 2 quarters · filed 2020-08-10 | 91.18M shares 10-Q · filed 2019-11-12 | 87.62M shares derived: average of 4 quarters · filed 2020-08-10 | |||||
| 2019-06-30 | 90.65M shares 10-Q · filed 2020-08-10 | 90.63M shares 10-Q · filed 2020-08-10 | 86.07M shares derived: average of 3 quarters · filed 2020-08-10 | 81.92M shares derived: average of 4 quarters · filed 2020-08-10 | |||||
| 2019-03-31 | 90.60M shares 10-Q · filed 2020-05-11 | 83.78M shares derived: average of 2 quarters · filed 2020-05-11 | 79.02M shares derived: average of 3 quarters · filed 2020-05-11 | 75.85M shares derived: average of 4 quarters · filed 2020-05-11 | |||||
| 2018-12-31 | 76.95M shares 10-K · filed 2019-03-18 | 73.22M shares derived: average of 2 quarters · filed 2019-11-12 | 70.94M shares derived: average of 3 quarters · filed 2019-11-12 | 69.32M shares 10-K · filed 2020-03-09 | |||||
| 2018-09-30 | 69.50M shares 10-Q · filed 2019-11-12 | 9.85M shares 10-Q · filed 2018-11-09 | 67.93M shares derived: average of 2 quarters · filed 2019-11-12 | 66.75M shares 10-Q · filed 2019-11-12 | 9.78M shares 10-Q · filed 2018-11-09 | 52.43M shares derived: average of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | 66.36M shares 10-Q · filed 2019-08-09 | 9.79M shares 10-Q · filed 2018-08-07 | 65.35M shares 10-Q · filed 2019-08-09 | 9.74M shares 10-Q · filed 2018-08-07 | 46.75M shares derived: average of 3 quarters · filed 2019-08-09 | 37.38M shares derived: average of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | 64.32M shares 10-Q · filed 2019-05-10 | 9.68M shares 10-Q · filed 2018-05-10 | 36.94M shares derived: average of 2 quarters · filed 2019-05-10 | 27.72M shares derived: average of 3 quarters · filed 2019-05-10 | 23.11M shares derived: average of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | 9.56M shares 10-K · filed 2018-03-14 | 9.42M shares derived: average of 2 quarters · filed 2018-11-09 | 9.37M shares derived: average of 3 quarters · filed 2018-11-09 | 63.88M shares 10-K · filed 2020-03-09 | 9.33M shares 10-K · filed 2018-03-14 | ||||
| 2017-09-30 | 9.28M shares 10-Q · filed 2018-11-09 | 9.28M shares 10-Q · filed 2017-11-14 | 9.27M shares derived: average of 2 quarters · filed 2018-11-09 | 9.26M shares 10-Q · filed 2018-11-09 | 9.26M shares 10-Q · filed 2017-11-14 | 9.24M shares derived: average of 4 quarters · filed 2018-11-09 | |||
| 2017-06-30 | 9.26M shares 10-Q · filed 2018-08-07 | 9.26M shares 10-Q · filed 2017-08-11 | 9.25M shares 10-Q · filed 2018-08-07 | 9.25M shares 10-Q · filed 2017-08-11 | 9.23M shares derived: average of 3 quarters · filed 2018-08-07 | 8.80M shares derived: average of 4 quarters · filed 2018-08-07 | |||
| 2017-03-31 | 9.24M shares 10-Q · filed 2018-05-10 | 9.24M shares 10-Q · filed 2017-05-12 | 9.21M shares derived: average of 2 quarters · filed 2018-05-10 | 8.64M shares derived: average of 3 quarters · filed 2018-05-10 | 8.36M shares derived: average of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | 9.18M shares 10-K · filed 2018-03-14 | 7.92M shares 10-K · filed 2017-03-28 | 8.34M shares derived: average of 2 quarters · filed 2018-03-14 | 8.06M shares derived: average of 3 quarters · filed 2018-03-14 | 63.20M shares 10-K · filed 2019-03-18 | 7.92M shares 10-K · filed 2017-03-28 | |||
| 2016-09-30 | 7.50M shares 10-K · filed 2018-03-14 | 7.50M shares derived: average of 2 quarters · filed 2018-03-14 | 7.50M shares 10-Q · filed 2017-11-14 | ||||||
| 2016-06-30 | 7.50M shares 10-K · filed 2018-03-14 | 7.50M shares 10-Q · filed 2017-08-11 | |||||||
| 2016-03-31 | 7.50M shares 10-K · filed 2018-03-14 | ||||||||
| 2015-12-31 | 7.50M shares 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |